NCT02176317 - Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Autism Spectrum Disorder

Interventions

BIOLOGICAL

Autologous Umbilical Cord Blood

All participants will receive autologous umbilical cord blood cells with a pre-cryopreservation cell dose of 1-5 x 10\^7 Total Nucleated Cells (TNC)/kilogram of subject body weight. The cells will be administered as a single intravenous (into the vein) infusion over 2 to 25 minutes

Trial Locations (1)

27705

Duke University Medical Center, Durham